Regulation of the p53 transcriptional response by structurally diverse core promoters.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMC 2807349)

Published in Genes Dev on December 29, 2009

Authors

José M Morachis1, Christopher M Murawsky, Beverly M Emerson

Author Affiliations

1: Regulatory Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037, USA.

Articles citing this

Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet (2011) 5.62

Paused Pol II coordinates tissue morphogenesis in the Drosophila embryo. Cell (2013) 2.42

Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle (2011) 2.01

Perspectives on the RNA polymerase II core promoter. Wiley Interdiscip Rev Dev Biol (2011) 1.81

Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev (2010) 1.76

iRegulon: from a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol (2014) 1.69

Another fork in the road--life or death decisions by the tumour suppressor p53. EMBO Rep (2013) 1.43

Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. Elife (2014) 1.41

The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Cell Cycle (2012) 1.24

NF-Y coassociates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. Genome Res (2013) 1.15

Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes Dev (2011) 1.11

SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing. Genes Dev (2011) 1.10

Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway. Cell Death Dis (2011) 1.04

Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2. Cell Death Dis (2015) 1.04

The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage. Oncogene (2012) 0.97

Small Genetic Circuits and MicroRNAs: Big Players in Polymerase II Transcriptional Control in Plants. Plant Cell (2016) 0.95

Highly redundant function of multiple AT-rich sequences as core promoter elements in the TATA-less RPS5 promoter of Saccharomyces cerevisiae. Nucleic Acids Res (2010) 0.94

Differential regulation of p53 target genes: it's (core promoter) elementary. Genes Dev (2010) 0.92

H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance. J Immunol (2015) 0.91

A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX. EMBO J (2012) 0.89

Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes. Cell Cycle (2010) 0.89

Absence of p53-dependent apoptosis leads to UV radiation hypersensitivity, enhanced immunosuppression and cellular senescence. Cell Cycle (2010) 0.89

Identification of kinase inhibitors that target transcription initiation by RNA polymerase II. Oncotarget (2011) 0.88

Long non-coding RNAs and p53 regulation. Int J Mol Sci (2012) 0.83

NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table. Cell Death Dis (2011) 0.83

Transcription factor Sp3 represses expression of p21CIP¹ via inhibition of productive elongation by RNA polymerase II. Mol Cell Biol (2013) 0.82

Non-coding RNAs in DNA damage response. Am J Cancer Res (2012) 0.79

The long reach of noncoding RNAs. Nat Genet (2011) 0.78

Census and evaluation of p53 target genes. Oncogene (2017) 0.77

Co-occurrence of transcription and translation gene regulatory features underlies coordinated mRNA and protein synthesis. BMC Genomics (2014) 0.77

Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2. Biomolecules (2015) 0.77

Targeting transcription through inhibition of TBP. Oncotarget (2011) 0.77

Investigating transcription reinitiation through in vitro approaches. Transcription (2014) 0.76

How p53 wields the scales of fate: arrest or death? Transcription (2012) 0.75

DTIE, a novel core promoter element that directs start site selection in TATA-less genes. Nucleic Acids Res (2015) 0.75

Articles cited by this

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30

WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72

Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75

The RNA polymerase II core promoter. Annu Rev Biochem (2003) 9.37

p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer (2009) 9.21

Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nat Rev Genet (2007) 5.75

The SV40 early region TATA box is required for accurate in vitro initiation of transcription. Nature (1981) 5.43

Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell (2004) 5.30

Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev (2000) 5.04

The molecular biology of the CCAAT-binding factor NF-Y. Gene (1999) 4.36

Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev (2006) 4.06

Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res (2001) 4.03

Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev (1995) 3.88

A transcription reinitiation intermediate that is stabilized by activator. Nature (2000) 3.65

Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters. Genes Dev (1996) 3.55

A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol (2008) 3.13

p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell (2003) 3.05

Functional steps in transcription initiation and reinitiation from the major late promoter in a HeLa nuclear extract. J Biol Chem (1987) 2.95

Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev (1999) 2.94

Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci U S A (2001) 2.92

Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev Biol (2009) 2.89

CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell (2007) 2.88

Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene (2006) 2.31

Roles of TATA and initiator elements in determining the start site location and direction of RNA polymerase II transcription. J Biol Chem (1992) 2.24

The gateway to transcription: identifying, characterizing and understanding promoters in the eukaryotic genome. Cell Mol Life Sci (2007) 2.20

Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci U S A (1995) 2.17

Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol (2005) 2.13

Cloning of yeast HAP5: a novel subunit of a heterotrimeric complex required for CCAAT binding. Genes Dev (1995) 2.00

ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer (2007) 1.94

Transcription initiation by RNA polymerase II in vitro. Properties of preinitiation, initiation, and elongation complexes. J Biol Chem (1987) 1.93

Assembly and disassembly of the Drosophila RNA polymerase II complex during transcription. J Biol Chem (1990) 1.89

Kinetics of p53 binding to promoter sites in vivo. Mol Cell Biol (2001) 1.87

TATA-binding protein-associated factor(s) in TFIID function through the initiator to direct basal transcription from a TATA-less class II promoter. EMBO J (1994) 1.79

Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem (2003) 1.60

Mechanisms of regulatory diversity within the p53 transcriptional network. Oncogene (2008) 1.57

TBP, Mot1, and NC2 establish a regulatory circuit that controls DPE-dependent versus TATA-dependent transcription. Genes Dev (2008) 1.57

Functional characterization of core promoter elements: DPE-specific transcription requires the protein kinase CK2 and the PC4 coactivator. Mol Cell (2005) 1.52

NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Mol Cell Biol (2005) 1.52

An acetylation switch in p53 mediates holo-TFIID recruitment. Mol Cell (2007) 1.48

Structure of the human APO-1 gene. Eur J Immunol (1994) 1.33

A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response. Nucleic Acids Res (2008) 1.32

Characterization of human Fas gene. Exon/intron organization and promoter region. J Immunol (1995) 1.25

CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res (1997) 1.24

Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J Biol Chem (2003) 1.23

A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. Mol Cell Biol (2005) 1.22

Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions. Oncogene (2004) 1.17

The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J Biol Chem (2003) 1.16

Uncoupling of initiation and reinitiation rates during HeLa RNA polymerase II transcription in vitro. Mol Cell Biol (1993) 1.05

Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. Int J Cancer (2006) 1.01

A rapid and efficient PCR-based method for synthesizing high-molecular-weight multimers of oligonucleotides. Biochem Biophys Res Commun (1994) 1.00

Functions of p53 in metabolism and invasion. Biochem Soc Trans (2009) 0.86

Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J Biol Chem (1998) 0.85

Characterization of p53-mediated up-regulation of CD95 gene expression upon genotoxic treatment in human breast tumor cells. J Biol Chem (2003) 0.81

Isolation and mass spectrometry of specific DNA binding proteins. Methods Mol Biol (2006) 0.80

Articles by these authors

Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev (2006) 4.06

Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell (2003) 3.06

p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell (2003) 3.05

Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary. Mol Cell (2009) 2.21

BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem (2008) 1.80

Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc Natl Acad Sci U S A (2004) 1.77

A methylation-mediator complex in hormone signaling. Genes Dev (2004) 1.61

An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer (2011) 1.58

Pointed and Tramtrack69 establish an EGFR-dependent transcriptional switch to regulate mitosis. Nat Cell Biol (2002) 1.24

The HS2 enhancer of the beta-globin locus control region initiates synthesis of non-coding, polyadenylated RNAs independent of a cis-linked globin promoter. J Mol Biol (2005) 1.23

Mechanisms of chromatin assembly and transcription. Curr Opin Cell Biol (2002) 1.10

Identification of kinase inhibitors that target transcription initiation by RNA polymerase II. Oncotarget (2011) 0.88

Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response. Mol Cell (2013) 0.87

Remodeling plans for cellular specialization: unique styles for every room. Curr Opin Genet Dev (2006) 0.87

Functional and molecular characterization of the role of CTCF in human embryonic stem cell biology. PLoS One (2012) 0.82

Two modes of degradation of the tramtrack transcription factors by Siah homologues. J Biol Chem (2007) 0.82